Skip to main content
Top
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Metastasis | Research article

SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-κB pathway activation

Authors: Yuyan Gao, Xianxiu Nan, Xinjue Shi, Xiaoqin Mu, Binbin Liu, Huifen Zhu, Bingqing Yao, Xinyi Liu, Tianyue Yang, Yiting Hu, Shulin Liu

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Background

Sterol-regulatory element binding protein 1 (SREBP1), an intracellular cholesterol sensor located in the endoplasmic reticulum, regulates the intracellular cholesterol by the Insig-Srebp-Scap pathway. Over-expression of SREBP1 can cause dyslipidemia. SREBP1 can regulate the metabolic pathway, and then promote the proliferation of tumor cells. However, there is no relevant research of metastasis and invasion in the field of colorectal cancer (CRC).

Methods

Expression of SREBP1 was manipulated in CRC cell lines with low and high level SREBP1 expression by transfectiong with plasmids containing the SREBP1 gene, or by shRNA. The effect of SREBP1 on cell migration was assayed. The expression of SREBP1, p65 and MMP7 were detected by western blot. Human umbilical vein endothelial cell was used for detection of angiogenesis by adding the culture supernatant from HT29 and SW620. The level of reactive oxygen species (ROS) was detected by Dihydroethidium (DHE) staining. NF-κB inhibitor SN50 was used to test the relationship of SREBP1, NF-κB pathway and MMP7.

Results

We found that the expression of SREBP1 in colon adenocarcinoma was significantly higher than that in noncancerous tissues, especially in the invasive tumor front including tumor budding. In vitro, SREBP1 over-expressed in colon cancer cell lines HT29 promoted angiogenesis in endothelial cells, increased ROS levels, phosphorylation of NF-κB-p65 and increases MMP7 expression. The effect of SREBP1 on expression of MMP7 was lost following treatment with the NF-κB inhibitor SN50.

Conclusion

Our results suggest that SREBP1 can promote the invasion and metastasis of CRC cells by means of promoting the expression of MMP7 related to phosphorylation of p65.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lin OS. Acquired risk factors for colorectal cancer. Methods Mol Biol. 2009;472:361–72.CrossRef Lin OS. Acquired risk factors for colorectal cancer. Methods Mol Biol. 2009;472:361–72.CrossRef
2.
go back to reference Takahashi H, Hosono K, Endo H, Nakajima A. Colon epithelial proliferation and carcinogenesis in diet-induced obesity. J Gastroenterol Hepatol. 2013;28(Suppl 4):41–7.CrossRef Takahashi H, Hosono K, Endo H, Nakajima A. Colon epithelial proliferation and carcinogenesis in diet-induced obesity. J Gastroenterol Hepatol. 2013;28(Suppl 4):41–7.CrossRef
3.
go back to reference Suchanek S, Grega T, Ngo O, Vojtechova G, Majek O, Minarikova P, Brogyuk N, Bunganic B, Seifert B, Dusek L, et al. How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia? World J Gastroenterol. 2016;22(36):8103–11.CrossRef Suchanek S, Grega T, Ngo O, Vojtechova G, Majek O, Minarikova P, Brogyuk N, Bunganic B, Seifert B, Dusek L, et al. How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia? World J Gastroenterol. 2016;22(36):8103–11.CrossRef
4.
go back to reference Hua XX, Wu J, Goldstein JL, Brown MS, Hobbs HH. Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. Genomics. 1995;25(3):667–73.CrossRef Hua XX, Wu J, Goldstein JL, Brown MS, Hobbs HH. Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. Genomics. 1995;25(3):667–73.CrossRef
5.
go back to reference Yokoyama C, Wang XD, Briggs MR, Admon A, Wu J, Hua XX, Goldstein JL, Brown MS. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell. 1993;75(1):187–97.CrossRef Yokoyama C, Wang XD, Briggs MR, Admon A, Wu J, Hua XX, Goldstein JL, Brown MS. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell. 1993;75(1):187–97.CrossRef
6.
go back to reference Han JB, Li EW, Chen LG, Zhang YY, Wei FC, Liu JY, Deng HT, Wang YG. The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. Nature. 2015;524(7564):243–6.CrossRef Han JB, Li EW, Chen LG, Zhang YY, Wei FC, Liu JY, Deng HT, Wang YG. The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. Nature. 2015;524(7564):243–6.CrossRef
7.
go back to reference Luo XJ, Cheng C, Tan ZQ, Li NM, Tang M, Yang LF, Cao Y. Emerging roles of lipid metabolism in cancer metastasis. Mol Cancer. 2017;16(1):76.CrossRef Luo XJ, Cheng C, Tan ZQ, Li NM, Tang M, Yang LF, Cao Y. Emerging roles of lipid metabolism in cancer metastasis. Mol Cancer. 2017;16(1):76.CrossRef
8.
go back to reference Tudek B, Zdzalik-Bielecka D, Tudek A, Kosicki K, Fabisiewicz A, Speina E. Lipid peroxidation in face of DNA damage, DNA repair and other cellular processes. Free Radic Biol Med. 2017;107:77–89.CrossRef Tudek B, Zdzalik-Bielecka D, Tudek A, Kosicki K, Fabisiewicz A, Speina E. Lipid peroxidation in face of DNA damage, DNA repair and other cellular processes. Free Radic Biol Med. 2017;107:77–89.CrossRef
9.
go back to reference Mo H, Elson CE. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood). 2004;229(7):567–85.CrossRef Mo H, Elson CE. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood). 2004;229(7):567–85.CrossRef
10.
go back to reference Gao YY, Li X, Yang M, Zhai Q, Liu XL, Wang GY, Lu XL, Wu Q, Wu J, Yang YM, et al. Colitis-accelerated colorectal cancer and metabolic dysregulation in a mouse model. Carcinogenesis. 2013;34(8):1861–9.CrossRef Gao YY, Li X, Yang M, Zhai Q, Liu XL, Wang GY, Lu XL, Wu Q, Wu J, Yang YM, et al. Colitis-accelerated colorectal cancer and metabolic dysregulation in a mouse model. Carcinogenesis. 2013;34(8):1861–9.CrossRef
11.
go back to reference Vazquez-Martin A, Colomer R, Brunet J, Lupu R, Menendez JA. Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptor in human breast epithelial cells. Cell Prolif. 2008;41:59–85.CrossRef Vazquez-Martin A, Colomer R, Brunet J, Lupu R, Menendez JA. Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptor in human breast epithelial cells. Cell Prolif. 2008;41:59–85.CrossRef
12.
go back to reference Lee JH, Jeon YG, Lee KH, Lee HW, Park J, Jang H, Kang M, Lee HS, Cho HJ, Nam DH, et al. RNF20 suppresses tumorigenesis by inhibiting SREBP1c-PTTG1 Axis in kidney Cancer. Mol Cell Biol. 2017;37:e00265–17.PubMedPubMedCentral Lee JH, Jeon YG, Lee KH, Lee HW, Park J, Jang H, Kang M, Lee HS, Cho HJ, Nam DH, et al. RNF20 suppresses tumorigenesis by inhibiting SREBP1c-PTTG1 Axis in kidney Cancer. Mol Cell Biol. 2017;37:e00265–17.PubMedPubMedCentral
13.
go back to reference Luo D, Xiao HW, Dong JL, Li Y, Feng GX, Cui M, Fan SJ. B7-H3 regulates lipid metabolism of lung cancer through SREBP1-mediated expression of FASN. Biochem Biophys Res Commun. 2017;482(4):1246–51.CrossRef Luo D, Xiao HW, Dong JL, Li Y, Feng GX, Cui M, Fan SJ. B7-H3 regulates lipid metabolism of lung cancer through SREBP1-mediated expression of FASN. Biochem Biophys Res Commun. 2017;482(4):1246–51.CrossRef
14.
go back to reference Shafiee MN, Mongan N, Seedhouse C, Chapman C, Deen S, Abu J, Atiomo W. Sterol regulatory element binding protein-1 (SREBP1) gene expression is similarly increased in polycystic ovary syndrome and endometrial cancer. Acta Obstet Gynecol Scand. 2017;96(5):556–62.CrossRef Shafiee MN, Mongan N, Seedhouse C, Chapman C, Deen S, Abu J, Atiomo W. Sterol regulatory element binding protein-1 (SREBP1) gene expression is similarly increased in polycystic ovary syndrome and endometrial cancer. Acta Obstet Gynecol Scand. 2017;96(5):556–62.CrossRef
15.
go back to reference Zhang JX, Wang XL, Vikash V, Ye Q, Wu DD, Liu YL, Dong WG. ROS and ROS-mediated cellular signaling. Oxidative Med Cell Longev. 2016;2016:1–18. Zhang JX, Wang XL, Vikash V, Ye Q, Wu DD, Liu YL, Dong WG. ROS and ROS-mediated cellular signaling. Oxidative Med Cell Longev. 2016;2016:1–18.
16.
go back to reference Ho BY, Wu YM, Chang KJ, Pan TM. Dimerumic acid inhibits SW620 cell invasion by attenuating H2O2-mediated MMP-7 expression via JNK/C-Jun and ERK/C-Fos activation in an AP-1-dependent manner. Int J Biol Sci. 2011;7(6):869–80.CrossRef Ho BY, Wu YM, Chang KJ, Pan TM. Dimerumic acid inhibits SW620 cell invasion by attenuating H2O2-mediated MMP-7 expression via JNK/C-Jun and ERK/C-Fos activation in an AP-1-dependent manner. Int J Biol Sci. 2011;7(6):869–80.CrossRef
17.
go back to reference Hotta K, Bodkin NL, Gustafson TA, Yoshioka S, Ortmeyer HK, Hansen BC. Age-related adipose tissue mRNA expression of ADD1/SREBP1, PPARgamma, lipoprotein lipase, and GLUT4 glucose transporter in rhesus monkeys. J Gerontol A Biol Sci Med Sci. 1999;54(5):B183–8.CrossRef Hotta K, Bodkin NL, Gustafson TA, Yoshioka S, Ortmeyer HK, Hansen BC. Age-related adipose tissue mRNA expression of ADD1/SREBP1, PPARgamma, lipoprotein lipase, and GLUT4 glucose transporter in rhesus monkeys. J Gerontol A Biol Sci Med Sci. 1999;54(5):B183–8.CrossRef
18.
go back to reference Chen J, Yue J, Liu Y, Liu J, Jiao KL, Teng MY, Hu CY, Zhen J, Wu MX, Li Z, et al. Blocking of STAT-3/SREBP1-mediated glucose-lipid metabolism is involved in dietary phytoestrogen-inhibited ovariectomized-induced body weight gain in rats. J Nutr Biochem. 2018;61:17–23.CrossRef Chen J, Yue J, Liu Y, Liu J, Jiao KL, Teng MY, Hu CY, Zhen J, Wu MX, Li Z, et al. Blocking of STAT-3/SREBP1-mediated glucose-lipid metabolism is involved in dietary phytoestrogen-inhibited ovariectomized-induced body weight gain in rats. J Nutr Biochem. 2018;61:17–23.CrossRef
19.
go back to reference Yin F, Sharen G, Yuan F, Peng Y, Chen R, Zhou X, Wei H, Li B, Jing W, Zhao J. TIP30 regulates lipid metabolism in hepatocellular carcinoma by regulating SREBP1 through the Akt/mTOR signaling pathway. Oncogenesis. 2017;6(6):e347.CrossRef Yin F, Sharen G, Yuan F, Peng Y, Chen R, Zhou X, Wei H, Li B, Jing W, Zhao J. TIP30 regulates lipid metabolism in hepatocellular carcinoma by regulating SREBP1 through the Akt/mTOR signaling pathway. Oncogenesis. 2017;6(6):e347.CrossRef
20.
go back to reference Chakraborty PK, Xiong X, Mustafi SB, Saha S, Dhanasekaran D, Mandal NA, McMeekin S, Bhattacharya R, Mukherjee P. Role of cystathionine beta synthase in lipid metabolism in ovarian cancer. Oncotarget. 2015;6(35):37367–84.CrossRef Chakraborty PK, Xiong X, Mustafi SB, Saha S, Dhanasekaran D, Mandal NA, McMeekin S, Bhattacharya R, Mukherjee P. Role of cystathionine beta synthase in lipid metabolism in ovarian cancer. Oncotarget. 2015;6(35):37367–84.CrossRef
21.
go back to reference Kleinerjr D, Stetler-Stevenson WG. Structural biochemistry and activation of matrix metalloproteases. Curr Opin Cell Biol. 1993;5(5):891–7.CrossRef Kleinerjr D, Stetler-Stevenson WG. Structural biochemistry and activation of matrix metalloproteases. Curr Opin Cell Biol. 1993;5(5):891–7.CrossRef
22.
go back to reference Storz P. Reactive oxygen species in tumor progression. Front Biosci. 2005;10:1881–96.CrossRef Storz P. Reactive oxygen species in tumor progression. Front Biosci. 2005;10:1881–96.CrossRef
23.
go back to reference Brown GT, Murray GI. Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis. J Pathol. 2015;237:273–81.CrossRef Brown GT, Murray GI. Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis. J Pathol. 2015;237:273–81.CrossRef
24.
go back to reference Conlon GA, Murray GI. Recent advances in understanding the roles of matrixmetalloproteinases in tumour invasion and metastasis. J Pathol. 2019;247:629–40.CrossRef Conlon GA, Murray GI. Recent advances in understanding the roles of matrixmetalloproteinases in tumour invasion and metastasis. J Pathol. 2019;247:629–40.CrossRef
25.
go back to reference Tsai SH, Huang PH, Hsu YJ, Peng YJ, Lee CH, Wang JC, Chen JW, Lin SJ. Inhibition of hypoxia inducible factor-1alpha attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases. Sci Rep. 2016;6:28612.CrossRef Tsai SH, Huang PH, Hsu YJ, Peng YJ, Lee CH, Wang JC, Chen JW, Lin SJ. Inhibition of hypoxia inducible factor-1alpha attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases. Sci Rep. 2016;6:28612.CrossRef
26.
go back to reference Wu H, Yu WH, Meng FS, Mi J, Peng J, Liu JZ, Zhang XD, Hai CX, Wang X. Polychlorinated biphenyls-153 induces metabolic dysfunction through activation of ROS/NF-kappaB signaling via downregulation of HNF1b. Redox Biol. 2017;12:300–10.CrossRef Wu H, Yu WH, Meng FS, Mi J, Peng J, Liu JZ, Zhang XD, Hai CX, Wang X. Polychlorinated biphenyls-153 induces metabolic dysfunction through activation of ROS/NF-kappaB signaling via downregulation of HNF1b. Redox Biol. 2017;12:300–10.CrossRef
Metadata
Title
SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-κB pathway activation
Authors
Yuyan Gao
Xianxiu Nan
Xinjue Shi
Xiaoqin Mu
Binbin Liu
Huifen Zhu
Bingqing Yao
Xinyi Liu
Tianyue Yang
Yiting Hu
Shulin Liu
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-5904-x

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine